13-102846322-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000123.4(ERCC5):c.56C>T(p.Pro19Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000693 in 1,613,932 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000123.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERCC5 | ENST00000652225.2 | c.56C>T | p.Pro19Leu | missense_variant | Exon 1 of 15 | NM_000123.4 | ENSP00000498881.2 | |||
BIVM-ERCC5 | ENST00000639435.1 | c.1451-5796C>T | intron_variant | Intron 11 of 24 | 5 | ENSP00000491742.1 | ||||
BIVM-ERCC5 | ENST00000639132.1 | c.764-5796C>T | intron_variant | Intron 10 of 23 | 5 | ENSP00000492684.1 |
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152126Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000585 AC: 146AN: 249366Hom.: 0 AF XY: 0.000570 AC XY: 77AN XY: 135158
GnomAD4 exome AF: 0.000706 AC: 1032AN: 1461806Hom.: 0 Cov.: 31 AF XY: 0.000715 AC XY: 520AN XY: 727206
GnomAD4 genome AF: 0.000572 AC: 87AN: 152126Hom.: 1 Cov.: 32 AF XY: 0.000525 AC XY: 39AN XY: 74314
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 19 of the ERCC5 protein (p.Pro19Leu). This variant is present in population databases (rs34291397, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with ERCC5-related conditions. ClinVar contains an entry for this variant (Variation ID: 134159). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30086788, 29641532, 27498913, 28137924, 24728327, 31937788, 30306255, 33821390) -
ERCC5: BP4 -
not specified Uncertain:1Other:1
Variant summary: ERCC5 c.56C>T (p.Pro19Leu) results in a non-conservative amino acid change located in the XPG, N-terminal domain (IPR006085) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00059 in 249366 control chromosomes. The observed variant frequency is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in ERCC5 causing Xeroderma Pigmentosum phenotype (0.00019). c.56C>T has been reported in the literature in several cancer cohorts (e.g., dosSantos_2022) and in a cohort of children with various rare genetic diseases (e.g., Chirita-Emandi_2020), but has not been reported in any individuals clearly affected with Xeroderma Pigmentosum to our knowledge. These reports therefore do not provide unequivocal conclusions about association of the variant with Xeroderma Pigmentosum. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31937788, 32573973, 36077770). ClinVar contains an entry for this variant (Variation ID: 134159). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
- -
Inborn genetic diseases Uncertain:1
The c.56C>T (p.P19L) alteration is located in exon 1 (coding exon 1) of the ERCC5 gene. This alteration results from a C to T substitution at nucleotide position 56, causing the proline (P) at amino acid position 19 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Cerebrooculofacioskeletal syndrome 3 Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Xeroderma pigmentosum, group G Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at